Von Eschenbach Andrew C.
- SEC CIK
- 0001536529
In the past year, 1 open-market purchase filing worth $79.9K and 1 sale filing worth $306.7K.
Current role at each company
- BLCO Bausch & Lomb CorpDirectoras of Aug 10, 2026
- TLSI TriSalus Life Sciences, Inc.Directoras of Aug 21, 2024
- CELU Celularity IncDirectoras of Jun 16, 2023
- Radius Health, Inc.Directoras of Aug 15, 2022
- BHC Bausch Health Companies Inc.Directoras of Aug 9, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $79.9K
- 1 filing
- Sold
- $306.7K
- 1 filing
- Net
- −$226.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Von Eschenbach Andrew C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BLCO Bausch & Lomb Corp
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 (view filing)8:57 PM ET | Aug 6-7 | 4 days | Von Eschenbach Andrew C.Director | SSaleCommon Shares, No Par Value | −18.6K | $16.53 | −$306.7K | −22.6%63.7K after | 2 lots |
| Mar 3, 2026 (view filing) | Feb 27 | 4 days | Von Eschenbach Andrew C.Director | PPurchaseCommon Shares, No Par Value | +4.36K | $18.31 | +$79.9K | +7.0%66.5K after | |
| May 6, 2025 (view filing) | May 2 | 4 days | Von Eschenbach Andrew C.Director | PPurchaseCommon Shares, No Par Value | +1.70K | $11.76 | +$19.9K | +4.2%41.7K after |
BHC Bausch Health Companies Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2021 (view filing) | Aug 5 | 4 days | Von Eschenbach Andrew C.Director | PPurchaseCommon Shares, No Par Value | +1.40K | $25.94 | +$36.3K | +3.8%38.6K after |